PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV)
Mexico·Clase II·III. Agentes de
diagnóstico·PRODUCTOS ROCHE, S.A.
DE C.V.·Registered January 11, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- COBAS® CMV ROCHE
- Trade Name (English)
- COBAS® CMV ROCHE
- Analysis ID
- 0086R2024 SSA
- Registration Date
- January 11, 2024
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV) (PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0086R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on January 11, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.